APA引文

Cao, S., Durrani, F. A., Toth, K., Rustum, Y. M., & Seshadri, M. (2011). Bevacizumab Enhances the Therapeutic Efficacy of Irinotecan against Human Head and Neck Squamous Cell Carcinoma Xenografts.

Citação norma Chicago

Cao, Shousong, Farukh A. Durrani, Karoly Toth, Youcef. M. Rustum, and Mukund Seshadri. Bevacizumab Enhances the Therapeutic Efficacy of Irinotecan against Human Head and Neck Squamous Cell Carcinoma Xenografts. 2011.

MLA引文

Cao, Shousong, et al. Bevacizumab Enhances the Therapeutic Efficacy of Irinotecan against Human Head and Neck Squamous Cell Carcinoma Xenografts. 2011.